Development and Evaluation of Mucoadhesive Chlorhexidine Tablet Formulations
Purpose: To formulate mucoadhesive chlorhexidine tablets and evaluate their drug release characteristics and mechanism.
Methods: Chlorhexidine buccal adhesive tablets were prepared by direct compression using a blend of hydroxypropyl methylcellulose (HPMC) and chitosan as the bioadhesive polymers. Their dissolution
properties were assessed according to USP 24 (paddle method). In order to determine the mode of drug release from the tablets, the release data were subjected to various release kinetic models. The
bioadhesive strength of the tablets was also evaluated. Results: The results showed that as the proportion of HPMC in the blend increased, drug release rate decreased, with the lowest release rate observed when HPMC alone was used as the bioadhesive polymer (p < 0.001). Both the type and ratio of the polymers used influenced release kinetics. Also,
bioadhesion force increased with increasing proportion of HPMC in the tablets, with the highest adhesion force shown when HPMC was the only polymer used, and lowest when chitosan was used alone (p < 0.01). Conclusion: The chlorhexidine formulations developed showed promise as a bioadhesive delivery system for the drug.
Mucoadhesive tablets; Chlorhexidine; HPMC; Chitosan; Release properties; Bioadhesive strength.
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.